Secondary Prevention of Cardiovascular Events With Long-Term Pravastatin in Patients With Diabetes or Impaired Fasting Glucose

2003313 citationsJournal Articlebronze Open Access

Authors

Anthony Keech · National Health and Medical Research Council

David Colquhoun · Wesley Research Institute

James D. Best · St Vincent's Hospital

Adrienne Kirby · University of Sydney

R. John Simes · University of Sydney

David Hunt · The Royal Melbourne Hospital

Wendy Hague ·

Abstract

Cholesterol-lowering treatment with pravastatin therapy prevents cardiovascular events, including stroke, in patients with diabetes or IFG and established CHD.

Topics & Keywords

Lipoproteins and Cardiovascular Health Antiplatelet Therapy and Cardiovascular Diseases Health Systems, Economic Evaluations, Quality of Life

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Diabetes Care

Volume 26, Issue 10, pp. 2713-2721

DOI: 10.2337/diacare.26.10.2713

Field-Weighted Citation Impact: 23.75